Wall Street Expects This Obesity Drug Stock to Skyrocket 35% Over the Next 12 Months

• click to rate

  Posted by Two Blokes May 16 - Filed in Stock - 4 views
  
  Bad news keeps coming for Novo Nordisk (NVO 2.58%). The Denmark-based drugmaker's share price has plunged roughly 55% below its high set last summer.